0001209191-21-014646.txt : 20210226
0001209191-21-014646.hdr.sgml : 20210226
20210226144253
ACCESSION NUMBER: 0001209191-21-014646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sarena Francis Willard
CENTRAL INDEX KEY: 0001423786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 21687510
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: 2 CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
DATE OF NAME CHANGE: 20020613
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-24
0
0001175505
FIVE PRIME THERAPEUTICS, INC.
FPRX
0001423786
Sarena Francis Willard
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Strategy Officer
Common Stock
2021-02-24
4
F
0
5100
25.71
D
126244
D
Common Stock
2021-02-25
4
F
0
1653
23.08
D
124591
D
Includes 4,917 shares acquired on November 15, 2020 pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.
/s/ Francis Sarena
2021-02-26